Valion Bio SEC Filings
NASDAQ: VBIOHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
2.14-0.07 (-3.17%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Valion Bio filing overview
This page lists 1 recent SEC filings by Valion Bio (VBIO), including 1 8-K. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Oct 8, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
VBIO SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 8, 2026 | 8-K | Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities | View on EDGAR |